DarioHealth Corp. announced on June 26, 2025, a strategic commercial agreement with GreenKey Health, a leader in value-based sleep health solutions. This collaboration marks Dario's entry into the $150 billion sleep apnea market, which affects over 29 million Americans. The partnership aims to deliver a comprehensive care program to payers nationwide, integrating behavioral health, sleep, and cardiometabolic care.
The joint initiative combines Dario's clinically validated cardiometabolic and behavioral AI-powered health solutions with GreenKey's 'sleep-first' approach to obstructive sleep apnea (OSA) management. This integrated solution targets Commercial, Administrative Services Only (ASO), Medicaid, and Medicare Advantage plans, as well as self-funded employers. The goal is to drive awareness and secure payer contracts through a robust multi-channel marketing plan.
Steven Nelson, Chief Commercial Officer at Dario, stated that this agreement is a pivotal step in reshaping how chronic conditions like sleep apnea and cardiometabolic disorders are addressed in tandem. He emphasized that this collaboration opens access to a multi-billion-dollar market and aligns with Dario's mission to provide integrated, data-driven solutions for prevalent and costly chronic conditions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.